A detailed history of Coston, Mc Isaac & Partners transactions in Zoetis Inc. stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 224 shares of ZTS stock, worth $36,892. This represents 0.01% of its overall portfolio holdings.

Number of Shares
224
Previous 224 -0.0%
Holding current value
$36,892
Previous $38,000 13.16%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$145.54 - $178.83 $145 - $178
1 Added 0.45%
224 $38,000
Q1 2023

Apr 19, 2023

SELL
$145.48 - $175.02 $4,364 - $5,250
-30 Reduced 11.86%
223 $37,000
Q2 2022

Sep 21, 2022

BUY
$155.97 - $200.09 $39,460 - $50,622
253 New
253 $43,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Coston, Mc Isaac & Partners Portfolio

Follow Coston, Mc Isaac & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coston, Mc Isaac & Partners, based on Form 13F filings with the SEC.

News

Stay updated on Coston, Mc Isaac & Partners with notifications on news.